Investor

The company's proprietary technology aims to reduce motion sickness in an extended reality environment by stimulating the inner ear's vestibular system.

The lawsuit, filed on behalf of purchasers of Veradigm's common stock, alleges the company and its executives overstated the business's historical revenues by at least $20 million.

The funds come two years after the company scored a $1.15 billion investment.

Informa Markets will manage the massive health technology conference, while HIMSS will continue overseeing content and programming.

Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.

Although investment slowed for startups, leaders noted several big deals in digital health, particularly among retail players.

Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.

Execs said investors will focus on companies with evidence of market fit, established business models and those achieving measurable health outcomes.   

The year was plagued by layoffs, slowing investments and an increased need for companies to prove their market value.

The U.S. International Trade Commission determined Apple Watches with ECG functionality violate AliveCor patents, but an import ban is on hold until appeals wrap up in a case before the U.S. Patent and Trademark Office's Patent Trial and Appeal Board.